Skip to main content
. 2023 May 3;14:1174289. doi: 10.3389/fimmu.2023.1174289

Figure 1.

Figure 1

Seroconversation rate in (A) the total study cohort after basic vaccination (2 dosages), (B) in patients not responding after the second vaccination receiving a third booster vaccination. Seroconversion rate after basic vaccination according to (C) patient age, (D) ongoing immunosuppressive therapy, (E) time interval from allo-SCT to 1. vaccination in months, and (F) immunoreconstition after allo-SCT.